论文部分内容阅读
目的探讨丹红注射液对老年退行性心脏瓣膜病伴左心功能不全的治疗作用。方法将123例老年退行性心脏瓣膜病伴左心功能不全患者随机分为2组,均予常规拜阿司匹林、他汀类、利尿药等药物治疗,治疗组在此基础上加用丹红注射液,2组均连续用药2周。治疗前后进行6min步行实验,测定高敏C反应蛋白,评定心功能的变化。结果治疗组总有效率明显高于对照组(P<0.05);治疗后6min步行实验,测定高敏C反应蛋白明显改善,与治疗前及对照组比较均有显著性差异(P<0.01或P<0.05)。治疗期间未见不良反应。结论丹红注射液是辅助治疗退行性心脏瓣膜病伴左心功能不全是一种有效而安全的药物。
Objective To investigate the therapeutic effect of Danhong injection on senile degenerative heart valve disease with left ventricular dysfunction. Methods A total of 123 elderly patients with degenerative valvular heart disease and left ventricular dysfunction were randomly divided into two groups. All patients were treated with conventional aspirin, statins, diuretics and other drugs. On the basis of this treatment, Danhong injection, 2 groups were treated for 2 weeks. Before and after treatment for 6min walking test, determination of high-sensitivity C-reactive protein, assessment of cardiac function changes. Results The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). After 6 minutes of treatment, the high sensitivity C-reactive protein was significantly improved after walking 6 minutes after treatment, which was significantly different from that before treatment and the control group (P <0.01 or P < 0.05). No adverse reactions during treatment. Conclusion Danhong injection is an effective and safe adjuvant treatment of degenerative heart valve disease with left ventricular dysfunction.